Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy

Mise à jour : Il y a 4 ans
Référence : NCT00272662

Femme et Homme

Extrait

The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of multiple subcutaneously administered injections of peginesatide in anemic cancer participants receiving chemotherapy.


Critère d'inclusion

  • Chemotherapy-induced Anemia ,Cancer

Liens